Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices 75285 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than December 4, 2023. 

A. Federal Reserve Bank of Boston 

(Prabal Chakrabarti, Senior Vice 

President) 600 Atlantic Avenue, Boston, 

Massachusetts 02210–2204. Comments 

can also be sent electronically to 

BOS.SRC.Applications.Comments@

bos.frb.org: 

1. Mutual Bancorp MHC, Hyannis, 

Massachusetts; to merge with Fidelity 

Mutual Holding Company Leominster, 

Massachusetts, and thereby indirectly 

acquire Life Design Holding Company, 

Hyannis, Massachusetts, and Fidelity 

Co-Operative Bank, Leominster, 

Massachusetts. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–24243 Filed 11–1–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Trauma Informed Care 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Trauma Informed Care, which is 

currently being conducted by the 

AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before December 4, 2023. 

ADDRESSES: 

Email submissions: epc@ahrq.hhs.gov 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857. 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E77D, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, Telephone: 301–427–1656 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Trauma Informed Care. 

AHRQ is conducting this review 

pursuant to Section 902 of the Public 

Health Service Act, 42 U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Trauma Informed Care. 

The entire research protocol is available 

online at: https://effectivehealthcare.

ahrq.gov/products/trauma-informedcare/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Trauma Informed Care 

helpful: 

D A list of completed studies that 

your organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 

outlining the relevant information in 

each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on topics not included in 

the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

https://www.effectivehealthcare.

ahrq.gov/email-updates. 

The review will answer the following 

questions. This information is provided 

as background. AHRQ is not requesting 

that the public provide answers to these 

questions. 

Key Questions (KQ) 

TIC for Adult Patients/Clients 

• KQ 1. What is the evidence of 

benefits and/or harms of TIC on 

outcomes for patients/clients? 

Æ KQ 1a. Which components (e.g., 

education and training of providers about 

trauma, screening patients, delivering pointof-care interventions [note this is not meant 

to include established evidence-based 

treatments for trauma-related disorders], 

referring patients/clients for various forms of 

additional assessment and treatment for 

indicated needs) of TIC models, and 

organizational and practice characteristics, 

are associated with benefits and/or harms? 

Æ KQ 1b. Do outcomes vary by patient/ 

client or clinical or organizational 

characteristics, including the nature, extent 

and timing of exposure (e.g., recent or 

ongoing vs. prior exposure in childhood)? 

TIC for Child and Adolescent Patients/ 

Clients 

• KQ 2. What is the evidence of 

benefits and/or harms of TIC on 

outcomes for patients/clients? 

Æ KQ 2a. Which components (e.g., 

education and training of providers about 

trauma, screening patients, delivering pointof-care interventions [note this is not meant 

to include indicated evidence-based 

treatments for trauma-related disorders], 

referring clients for various forms of 

additional assessment and treatment for 

indicated needs) of TIC models, 

organizational and practice characteristics, 

are associated with benefits and/or harms? 


khammond on DSKJM1Z7X2PROD with NOTICES
75286 Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices 

Æ KQ 2b. Do outcomes vary by patient/ 

client (as well as parent) or clinical or 

organizational characteristics including the 

nature, extent, and timing of exposure (e.g., 

recent or ongoing vs. prior exposure)? 

PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTING) 

PICOTS KQ1 KQ2 

Population ............................ Adults 18 years and older, regardless of trauma exposure.Youth <18 years, regardless of trauma exposure. 

1b. Patient/client and clinical characteristics including 

type, time since, and duration of trauma exposure; 

gender; race/ethnicity; age; clinical condition; or disorder (e.g., anxiety, depression, substance use).

2b. Patient/client and clinical characteristics including 

type, time since, and duration of trauma exposure; 

gender; race/ethnicity; age; clinical condition; or disorder, (e.g., anxiety, depression, ADHD, conduct disorder, substance use). 

Intervention .......................... TIC models/components of care (e.g., education and 

training of providers about trauma, screening patients/clients for trauma exposure using ACEs or 

other tools, screening for symptoms, delivering pointof-care interventions, referring patients/clients for various forms of additional assessment and treatment 

for indicated needs).

TIC models/components of care (e.g., education and 

training of providers about trauma, screening patients/clients for trauma exposure using ACEs or 

other tools, screening for symptoms, delivering point 

of care interventions, referring patients/clients for various forms of additional assessment and treatment 

for indicated needs). 

1a. single or multi-component, individual or group, targeting organizations, providers, patients/clients, caregivers, or a combination, training, screening.2a. single or multi-component, individual or group, targeting organizations, providers, patients/clients, caregivers, or a combination, training, screening. 

Comparator .......................... No TIC model of care/usual or routine care (CAU) ........ No TIC model of care/usual or routine care (CAU). 

Other TIC model or component(s) of care, evidencebased therapies for trauma-related conditions (e.g., 

prolonged exposure, cognitive processing therapy) or 

approaches (e.g., Collaborative Care).

Other TIC model or component(s) of care, evidencebased therapies for trauma-related conditions (e.g., 

trauma-focused CBT) or approaches (e.g., Collaborative Care). 

Outcome ............................... Trauma-Specific: Additional or repeat trauma exposure 

from the point-of-care in the course of care/service 

delivery (e.g., retraumatization).

Trauma-Specific: Additional or repeat trauma exposure 

from the point-of-care in the course of care/service 

delivery (e.g., retraumatization). 

Process outcomes: Health care outcomes/utilization/referral, provider burnout/mental health.Process outcomes: Healthcare outcomes/utilization/referral, provider outcomes burnout/mental health. 

Organizational/practice/systems outcomes: Intake and 

referral processes (e.g., wait times), disseminated 

policies, trainings, staffing (e.g., scribes), administrative requirements, access to treatment, workforce diversity.

Organizational/practice/systems outcomes: Intake and 

referral processes (e.g., wait times), disseminated 

policies, trainings, staffing (e.g., scribes), administrative requirements, access to treatment, workforce diversity, anti-racism principles. 

Patient/client-centered outcomes: Physical and mental 

health outcomes, functioning, clinical improvement, 

patient/client engagement, trust, comfort or satisfaction, and strengths-based outcomes (e.g., quality of 

life).

Patient/client-centered outcomes: Physical and mental 

health outcomes, functioning, clinical improvement, 

patient/client engagement, trust, comfort or satisfaction, and strengths-based outcomes (e.g., quality of 

life). 

Harms: Includes displacement of evidence based care 

(e.g., screening for anxiety, depression, substance 

use, suicide risk), increase in patient/client aggression or other behavioral misconduct.

Harms: Includes displacement of evidence based care 

(e.g., screening for developmental milestones, 

ADHD, depression, anxiety, suicide risk, substance 

use), increase in patient/client aggression or other 

behavioral misconduct. 

Timing .................................. Any .................................................................................. Any. 

Setting .................................. Routine or emergency healthcare in any setting that 

provides human or social services, including in nontraditional settings (e.g., HIV clinics providing behavioral health care).

Routine or emergency healthcare in any setting that 

provides human or social services, including in nontraditional settings (e.g., school-based clinics providing behavioral health care). 

Dated: October 27, 2023. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2023–24214 Filed 11–1–23; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C. 1009(d), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)– 

TS24–010, Identify and Evaluate 

Potential Risk Factors for Amyotrophic 

Lateral Sclerosis (ALS). 

Date: April 9, 2024. 

Time: 8:30 a.m.–5 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Mikel L. Walters, Ph.D., Scientific 

Review Officer, National Center for 


khammond on DSKJM1Z7X2PROD with NOTICES